Job Description

BUSINESS:

Piramal Pharma Limited

DEPARTMENT:

Global Business Shared Services (GBSS)

LOCATION:

Kula Mumbai

BAND

: 1

TRAVEL:

Nil

KEY STAKHOLDERS INTERNAL : -

Business Supply Chain team, Business Development team, Finance, Accounts Payable, Accounts Receivable

KEY STAKHOLDERS EXTERNAL :

Customers, vendors


Responsible for creation/change/review of primarily Material/SKU & Price Masters and secondary responsibility of Vendor Masters. Customer and BOM etc.). Support SAP implementation projects (for SAP S4 HANA during UAT) by representing the MDM function. Participate in SAP MDG configuration discussions and UAT Perform quarterly reviews of the existing master data to check the data duplicity, adequacy, accuracy and compliance. Correct the outliers and fix the root cause. Support project teams during data cleansing and migration activities. Perform the business policy and data accuracy checks on the request received from requestor for master data creation/change Maintain the SLA adherence (99% request to be completed in 1 working day) with 100 % accuracy Data Governance to ensure that Masters are created complying statutory and legal framework. Educate the stakeholders for policy related compliances required Maintain good master data hygiene to ensure there are no duplicate master records, incomplete masters , incorrect /invalid information. Understand customer priorities and accordingly deliver the master data requirement Continue the development of data standards, processes and procedure for various master data domains Work with SAP IT team or RPA team to develop or improve the automation levels as well as system based controls in Master Data Management Process. Timely generation of MIS related to Master Data Management.

In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth.
Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices.

Equal employment opportunity

Piramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer. We do not discriminate based upon race, ethnicity, religion, color, national origin, gender (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity, gender expression, age, status as a protected veteran, status as an individual with a disability, genetics, or other applicable legally protected characteristics.



We base our employment decisions on merit considering qualifications, skills, performance, and achievements. We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters, including recruitment, selection, training, placement, promotion, demotion, compensation and benefits, transfers, terminations, and working conditions, including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice.

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products.


PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies. PCC's complex hospital product portfolio includes inhalation anaesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anaesthetics, injectable anti-infectives, and other therapies. The Indian Consumer Healthcare business is among the leading players in India in the self-care space, with established brands in the Indian consumer healthcare market. In addition, PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, the company received a growth equity investment from the Carlyle Group.